
STS NATIONAL CARDIAC SURGERY DATABASE
1996 CAB ONLY PATIENTS
UNIVARIATE ANALYSIS: PREOPERATIVE RISK VARIABLES
PATIENT POPULATION: 170,895
OPERATIVE SURVIVORS: 165,867
OPERATIVE MORTALITIES: 5,028
RISK VARIABLE | Count | % of Pop. | Mortality w/Variable Present |
| Mortality w/Variable Absent |
| Rela-tive Risk | c 2 p-Value |
Male | 121,575 | 71.14% | 3,044/121,575 | 2.50% | 1,984/ | 4.02% | 0.62 | 0.0000 |
Female | 49,320 | 28.86% | 1,984/49,320 | 4.02% | 3,044/ | 2.50% | 1.61 | 0.0000 |
Caucasian | 148,357 | 86.81% | 4,308/148,357 | 2.90% | 720/22,538 | 3.19% | 0.91 | 0.0161 |
Non-Caucasian | 22,538 | 13.19% | 720/22,538 | 3.19% | 4,308/ | 2.90% | 1.10 | 0.0161 |
Smoking History | 98,745 | 57.78% | 2,704/98,745 | 2.74% | 2,324/ | 3.22% | 0.85 | 0.0000 |
Family History | 79,684 | 46.63% | 1,961/79,684 | 2.46% | 3,067/ | 3.36% | 0.73 | 0.0000 |
Diabetes | 50,138 | 29.34% | 1,825/50,138 | 3.64% | 3,203/ | 2.65% | 1.37 | 0.0000 |
Morbid Obesity | 20,245 | 11.85% | 645/20,245 | 3.19% | 4,383/ | 2.91% | 1.10 | 0.0288 |
Hypercholesterolemia | 86,302 | 50.50% | 2,181/86,302 | 2.53% | 2,847/ | 3.37% | 0.75 | 0.0000 |
Renal Failure | 7,195 | 4.21% | 634/7,195 | 8.81% | 4,394/ | 2.68% | 3.28 | 0.0000 |
Renal Failure Requiring Dialysis | 1,512 | 0.88% | 146/1,512 | 9.66% | 4,882/ | 2.88% | 3.35 | 0.0000 |
Hypertension | 109,122 | 63.85% | 3,483/109,122 | 3.19% | 1,545/ | 2.50% | 1.28 | 0.0000 |
Pulmonary Hypertension | 4,781 | 2.80% | 355/4,781 | 7.43% | 4,673/ | 2.81% | 2.64 | 0.0000 |
CVA | 10,644 | 6.23% | 588/10,644 | 5.52% | 4,440/ | 2.77% | 1.99 | 0.0000 |
Endocarditis | 2,094 | 1.23% | 55/2,094 | 2.63% | 4,973/ | 2.95% | 0.89 | 0.3898 |
Cardiomegaly | 15,535 | 9.09% | 852/15,535 | 5.48% | 4,176/ | 2.69% | 2.04 | 0.0000 |
COPD | 25,886 | 15.15% | 1,157/25,886 | 4.47% | 3,871/ | 2.67% | 1.67 | 0.0000 |
Immuno-suppressive Rx | 2,073 | 1.21% | 103/2,073 | 4.97% | 4,925/ | 2.92% | 1.70 | 0.0000 |
Peripheral Vascular Disease | 122 | 0.07% | 5/122 | 4.10% | 5,023/ | 2.94% | 1.39 | 0.4497 |
Cerebrovascular Disease | 15,823 | 9.26% | 868/15,823 | 5.49% | 4,160/ | 2.68% | 2.04 | 0.0000 |
Prior CAB | 13,539 | 7.92% | 945/13,539 | 6.98% | 4,083/ | 2.59% | 2.69 | 0.0000 |
Prior Valve | 331 | 0.19% | 30/331 | 9.06% | 4,998/ | 2.93% | 3.09 | 0.0000 |
Prior Other Cardiac | 2,449 | 1.43% | 140/2,449 | 5.72% | 4,888/ | 2.90% | 1.97 | 0.0000 |
Prior Non-Cardiac | 10,112 | 5.92% | 595/10,112 | 5.88% | 4,433/ | 2.76% | 2.13 | 0.0000 |
Prior Non-Surgical | 39,293 | 22.99% | 1,138/39,293 | 2.90% | 3,890/ | 2.96% | 0.98 | 0.5389 |
PTCA To OR <6Hrs | 3,266 | 1.91% | 268/3,266 | 8.21% | 4,760/ | 2.84% | 2.89 | 0.0000 |
PTCA To OR >6Hrs | 13,286 | 7.77% | 370/13,286 | 2.78% | 4,658/ | 2.96% | 0.94 | 0.2640 |
Pior MI <6 Hrs vs. No MI | 2,646 | 1.55% | 279/2,646 | 10.54% | 2,069/ | 2.24% | 4.72 | 0.0000 |
Prior MI 6 to 24 Hrs vs. No MI | 2,961 | 1.73% | 265/2,961 | 8.95% | 2,069/ | 2.24% | 4.00 | 0.0000 |
Prior MI 1-7 Days vs. No MI | 26,604 | 15.57% | 983/26,604 | 3.69% | 2,069/ | 2.24% | 1.65 | 0.0000 |
Prior MI 7-21 Days vs. No MI | 8,154 | 4.77% | 306/8,154 | 3.75% | 2,069/ | 2.24% | 1.68 | 0.0000 |
Prior MI >21 Days vs. No MI | 37,958 | 22.21% | 1,126/37,958 | 2.97% | 2,069/ | 2.24% | 1.33 | 0.0000 |
Congestive Heart Failure | 21,921 | 12.83% | 1,466/21,921 | 6.69% | 3,562/ | 2.39% | 2.80 | 0.0000 |
Unstable Angina | 92,427 | 54.08% | 3,202/92,427 | 3.46% | 1,826/ | 2.33% | 1.49 | 0.0000 |
Cardiogenic Shock | 2,849 | 1.67% | 571/2,849 | 20.04% | 4,457/ | 2.65% | 7.56 | 0.0000 |
Resuscitation | 2,130 | 1.25% | 302/2,130 | 14.18% | 4,726/ | 2.80% | 5.06 | 0.0000 |
Arrhythmia | 21,462 | 12.56% | 1,185/21,462 | 5.52% | 3,843/ | 2.57% | 2.15 | 0.0000 |
Digitalis | 16,306 | 9.54% | 871/16,306 | 5.34% | 4,157/ | 2.69% | 1.99 | 0.0000 |
Beta Blockers | 76,957 | 45.03% | 2,020/76,957 | 2.62% | 3,008/ | 3.20% | 0.82 | 0.0000 |
Ca Antagonists | 57,379 | 33.58% | 1,777/57,379 | 3.10% | 3,251/ | 2.86% | 1.08 | 0.0071 |
ACE Inhibitors | 36,579 | 21.40% | 1,282/36,579 | 3.50% | 3,746/ | 2.79% | 1.26 | 0.0000 |
Nitrates - P.O. | 67,457 | 39.47% | 2,024/67,457 | 3.00% | 3,004/ | 2.90% | 1.03 | 0.2496 |
Nitrates - I.V. | 44,119 | 25.82% | 1,869/44,119 | 4.24% | 3,159/ | 2.49% | 1.70 | 0.0000 |
Antiarrhythmics | 8,112 | 4.75% | 470/8,112 | 5.79% | 4,558/ | 2.80% | 2.07 | 0.0000 |
Antiplatelets | 73,554 | 43.04% | 2,045/73,554 | 2.78% | 2,983/ | 3.06% | 0.91 | 0.0006 |
Anticoagulants | 66,186 | 38.73% | 2,400/66,186 | 3.63% | 2,628/ | 2.51% | 1.44 | 0.0000 |
Diuretics | 33,056 | 19.34% | 1,620/33,056 | 4.90% | 3,408/ | 2.47% | 1.98 | 0.0000 |
Inotropes | 3,679 | 2.15% | 475/3,679 | 12.91% | 4,553/ | 2.72% | 4.74 | 0.0000 |
Steroids | 4,357 | 2.55% | 237/4,357 | 5.44% | 4,791/ | 2.88% | 1.89 | 0.0000 |
Aspirin | 106,489 | 62.31% | 2,918/106,489 | 2.74% | 2,110/ | 3.28% | 0.84 | 0.0000 |